SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-076542
Filing Date
2020-06-24
Accepted
2020-06-24 19:48:53
Documents
1
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2022959d1_4.html 4  
1 OWNERSHIP DOCUMENT tm2022959d1_4.xml 4 5773
  Complete submission text file 0001104659-20-076542.txt   7490
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XTL BIOPHARMACEUTICALS LTD 711 EXECUTIVE BLVD., SUITE Q VALLEY COTTAGE NY 10989
Business Address
KENNEDY WILLIAM JAMES (Reporting) CIK: 0001448888 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 20986762